News
The Malawi Ministry of Health, bioMérieux, and Pfizer today announced a collaboration to advance Malawi’s first multisectoral initiative which aims to build public sector antimicrobial stewardship (AMS) capacity in infection prevention and control, diagnostics, surveillance, and to guide the appropriate use of antibiotics.
Swipe to discover more
-
bioMérieux presents its new 5-year strategic plan and its targets for profitable growth
bioMérieux, a world leader in the field in vitro diagnostics, is hosting today a Capital Markets Day in Paris. On this occasion, Pierre Boulud, Chief Executive Officer, together with members of the Executive Committee will present bioMérieux’s strategic plan, GO•28, the new chapter for the Company’s growth and development. -
Diagnostic Stewardship: choosing the right test
Clinical labs are often faced with the challenge of needing to be better, faster, and more productive – while sometimes expected to do so with fewer resources and contending with supply chain issues. With the continued focus on value-based care as a main objective in healthcare, optimizing the utilization of diagnostic testing is more important than ever. -
bioMérieux Named Business of the Year by Utah Governor’s Office of Economic Opportunity
bioMérieux, a world leader in the field of in vitro diagnostics, has received the 2024 Business of the Year Award, presented by the Utah Governor’s Office of Economic Opportunity at One Utah Summit April 11-12, in Salt Lake City.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19